Experiencing moderate to severe acute pain related to: 1) An ambulatory surgical procedure expected to cause pain lasting at least 72 hours, or 2) A traumatic or non-traumatic musculoskeletal condition.
Have a pain score of at least 4 on a 0 to 10 pain rating scale before starting study treatment.
Willing and able to comply with study requirements
You may not be if
Chronic pain condition that requires ongoing pain medication.
Significant medical or psychiatric condition that could affect participation or study results.
History of substance use disorder or misuse of alcohol or drugs.
Current use of medications that may interfere with the study drug or pain assessments.
Known allergy or intolerance to cebranopadol or permitted rescue pain medications.
Pregnant or breastfeeding.
Participation in another clinical trial or receipt of an investigational drug within the protocol-defined period before study entry.
Any condition that, in the investigator's opinion, would make participation unsafe or interfere with study assessments.
Clareo Health | An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
